COOKSON PEIRCE & CO INC

Position in GILD — Gilead Sciences, Inc.

CIK 1141455 PITTSBURGH, PA

Position in GILD

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$1,207,362

-$176,531 QoQ

Shares Held

8,663

-23.2% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2025

4 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

COOKSON PEIRCE & CO INC holds $103,842,214 across 6 Drug Manufacturers - General names. GILD ranks #4 (1.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	61,609	$56,666,109
2	NVS	Novartis AG	283,617	$43,322,496
3	AZN	Astrazeneca PLC	8,635	$1,702,994
4	GILD	Gilead Sciences, Inc. This page	8,663	$1,207,362
5	BMY	Bristol Myers Squibb Co	9,519	$577,327
6	JNJ	Johnson & Johnson	1,497	$365,926

4 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,207,362	8,663	-23.2%	Shares	Sole	2026-04-30
2025-12-31	$1,383,893	11,275	+12.2%	Shares	Sole	2026-02-11
2025-09-30	$1,114,995	10,045	+249.1%	Shares	Sole	2025-11-06
2025-06-30	$318,972	2,877	—	Shares	Sole	2025-07-30
No filing history on record for this holder in this stock.